Yi Chen

Stock Analyst at HC Wainwright & Co.

(1.04)
# 2086
Out of 5,354 analysts
630
Total ratings
38.63%
Success rate
-4.03%
Average return
62 Stocks
Name Action PT Current % Upside Ratings Updated
OCUL Ocular Therapeutix
Reiterates: Buy
15 15
8.45 77.51% 27 May 29, 2025
EYPT EyePoint Pharmaceuti...
Reiterates: Buy
22 22
8.09 171.94% 22 May 29, 2025
ICCM Icecure Medical
Reiterates: Buy
3 3
1.02 145.1% 21 May 29, 2025
LPCN Lipocine
Assumes: Buy
8
3.24 146.91% 1 May 29, 2025
NPCE NeuroPace
Initiates Coverage On: Buy
18
13.64 31.96% 1 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 5
0.76 557.89% 21 May 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 12
3.98 201.51% 22 May 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
4 4
1.12 257.14% 6 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
51 53
29.5 79.66% 4 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
100 100
65.06 53.7% 19 May 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
21.95 36.67% 2 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
57 60
29.55 103.05% 4 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
25 25
19.07 31.1% 12 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
1.88 272.34% 13 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50 50
18.69 167.52% 7 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 15
11.52 30.21% 18 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 8
2.16 270.37% 22 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
14 14
12.49 12.09% 9 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
9 9
2.95 205.08% 18 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
38 39
9.32 318.45% 8 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 32
19.09 67.63% 14 Apr 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
0.57 338.6% 2 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
3.7 170.27% 1 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
1.37 118.98% 14 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
15 16
10.91 46.65% 10 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
4.83 148.45% 19 Apr 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 12
3.29 264.74% 4 Apr 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
0.96 212.5% 1 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 1
0.29 244.83% 23 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
3.2 212.5% 16 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
2.75 154.55% 19 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
1.02 194.12% 13 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
34 34
10.01 239.66% 10 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 7
0.94 644.68% 5 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
0.65 361.54% 20 Jan 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 10 Nov 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3 3
n/a n/a 9 Jul 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
6
n/a n/a 17 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5250 1125
n/a n/a 18 Jun 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
0.28 3471.43% 5 May 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
72 72
n/a n/a 19 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Neutral
n/a
n/a n/a 12 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
11 11
0.38 2794.74% 14 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
38
n/a n/a 9 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 3
n/a n/a 4 Aug 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 6 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
2
n/a n/a 8 Jun 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15
n/a n/a 7 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 7 Jun 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
6
n/a n/a 10 Apr 19, 2023